Hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2−) BC accounts for approximately two-thirds of all breast cancers and as a result, hormone therapy plays an integral role in breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.